Long COVID and POTS: Understanding Autonomic Dysfunction After COVID-19

Long COVID, also known as Post-Acute Sequelae of SARS-CoV-2 infection (PASC), has emerged as a significant global health challenge. Millions worldwide grapple with persistent, debilitating symptoms long after acute infection. Among these, issues related to the autonomic nervous system (ANS) are particularly prominent, with Postural Orthostatic Tachycardia Syndrome (POTS) being a frequently observed and profoundly disruptive condition. This article explores the intricate connection between Long COVID and autonomic dysfunction, why POTS is common after COVID-19, underlying mechanisms like autoimmunity and mast cell activation, and current treatment strategies to help patients and caregivers. For more, see our complete guide to POTS. For more, see our POTS treatment options.

Understanding the Autonomic Nervous System and COVID-19's Impact

The autonomic nervous system (ANS) is the body's control center for involuntary functions, including heart rate, blood pressure, digestion, and temperature regulation. It operates without conscious effort, maintaining a delicate internal balance (homeostasis). The ANS has two main branches: the sympathetic ("fight or flight") and parasympathetic ("rest and digest") nervous systems.

When this intricate system malfunctions, it leads to autonomic dysfunction or dysautonomia. This disrupts communication between the brain and organs, causing inappropriate responses to stimuli. For example, standing can cause a drastic drop in blood pressure or a skyrocketing heart rate.

COVID-19, caused by the SARS-CoV-2 virus, is now recognized as a systemic disease affecting multiple organ systems, including the nervous system. Evidence suggests the virus can directly or indirectly trigger autonomic dysfunction, leading to persistent symptoms. Widespread inflammation, endothelial dysfunction, and immune dysregulation caused by the virus can create a hostile environment for autonomic nerves. This manifests as persistent fatigue, brain fog, cardiovascular irregularities, gastrointestinal distress, and temperature intolerance.

The Prevalence of POTS in Long COVID Patients

POTS is a common form of dysautonomia characterized by an abnormal and sustained increase in heart rate upon standing. A diagnosis typically requires a heart rate increase of at least 30 beats per minute (or 40 bpm in adolescents) within 10 minutes of standing, without orthostatic hypotension (significant blood pressure drop). This rapid heart rate is often accompanied by severe dizziness, lightheadedness, palpitations, chest pain, shortness of breath, profound fatigue, and brain fog. Symptoms usually improve when lying down.

Since the pandemic, POTS has been increasingly recognized as a common and debilitating sequela of COVID-19. Many Long COVID patients develop POTS-like symptoms or receive a formal diagnosis. The overlap between Long COVID and POTS symptoms is striking, prompting close investigation.

Studies indicate a notable prevalence of POTS among individuals with Long COVID. Research shows a substantial percentage of patients with persistent cardiovascular and neurological symptoms after COVID-19 meet POTS diagnostic criteria [1]. Some studies suggest up to 30% of Long COVID patients may experience dysautonomia, with POTS being the most frequent presentation. This high incidence highlights the urgent need for increased awareness, early recognition, and routine screening for autonomic dysfunction in the Long COVID population. The demographic most affected by POTS—young to middle-aged women—also mirrors the demographic most frequently reporting Long COVID symptoms, further emphasizing the link.

Proposed Mechanisms: Why COVID-19 Triggers POTS

The exact mechanisms by which COVID-19 leads to POTS are under intense investigation. Several compelling theories point to a complex interplay of immunological, neurological, and inflammatory factors. It is likely that POTS in Long COVID is caused by a combination of these factors:

Autoantibodies and Autoimmunity

One leading hypothesis involves autoimmunity and the production of autoantibodies. In some individuals, the immune response triggered by COVID-19 goes awry, causing the body to mistakenly produce autoantibodies that attack its own healthy tissues and receptors.

Researchers have identified specific autoantibodies that target G-protein coupled receptors, crucial for regulating the autonomic nervous system, including heart rate and blood vessel constriction. When these autoantibodies bind, they disrupt normal signaling, leading to the cardiovascular irregularities seen in POTS [2]. This autoimmune phenomenon is not unique to COVID-19 and has been observed in other post-viral syndromes. "Molecular mimicry," where viral components resemble human proteins, may explain this immune confusion.

Small Fiber Neuropathy

Small fiber neuropathy (SFN) is another strongly supported mechanism for Long COVID-associated POTS. SFN involves damage to small, unmyelinated or thinly myelinated nerve fibers in the peripheral nervous system. These fibers transmit sensory information (pain, temperature) and control autonomic functions (sweating, blood vessel constriction/dilation).

Systemic inflammation and immune dysregulation from COVID-19 can damage these small nerve fibers, particularly in the skin and internal organs. When nerve fibers controlling blood vessels are damaged, vessels may fail to constrict properly upon standing. This leads to blood pooling in the lower extremities and abdomen. To compensate for reduced blood flow to the heart and brain, the heart beats faster, causing the characteristic tachycardia of POTS [3]. Patients with Long COVID and POTS often show objective evidence of SFN via skin biopsies.

Mast Cell Activation Syndrome (MCAS)

Mast cell activation syndrome (MCAS) is increasingly recognized as a comorbid condition with POTS and a potential driver of Long COVID symptoms. Mast cells are immune cells that, in MCAS, become overly sensitive and inappropriately release excessive inflammatory mediators (histamine, cytokines, prostaglandins).

Evidence links COVID-19's hyper-inflammatory state to triggering or exacerbating MCAS. These mediators profoundly affect the ANS. Histamine, a potent vasodilator, causes blood vessels to widen, contributing to blood pooling and a drop in blood pressure upon standing, which triggers rapid heart rate in POTS [4]. MCAS can also cause other common Long COVID symptoms, including gastrointestinal issues, rashes, flushing, and severe fatigue.

Current Treatment Approaches for Long COVID-Associated POTS

Managing POTS in Long COVID is challenging and requires an individualized, multi-faceted approach. There is no single "cure," so treatment focuses on symptom management, lifestyle modifications, and addressing underlying causes. A collaborative approach with cardiologists, neurologists, and physical therapists is often most effective.

Lifestyle Modifications

Simple yet effective lifestyle adjustments are often the first line of treatment, forming the foundation of POTS management:

• Increased Fluid and Salt Intake: Consuming 2-3 liters of water and 3,000-10,000 mg of sodium daily helps expand blood volume, counteracting blood pooling and improving blood pressure regulation and heart rate spikes.
• Compression Garments: Medical-grade compression garments prevent blood pooling in the lower body. Waist-high compression tights or abdominal binders are generally more effective.
• Graded Exercise Program: While exercise can trigger symptom flares, a carefully structured, graded exercise program is beneficial. Programs like CHOP start with recumbent exercises (rowing, recumbent biking) to avoid orthostatic stress, gradually building cardiovascular conditioning and muscle strength.
• Dietary Adjustments: Smaller, more frequent, lower-carbohydrate meals can manage post-meal symptom flares. A low-histamine diet may be recommended if MCAS is suspected.
• Pacing and Energy Conservation: Learning to pace activities and avoid pushing through fatigue is crucial for managing energy limitations common in both POTS and Long COVID.

Medications

When lifestyle modifications are insufficient, several medications can be prescribed to manage POTS symptoms, often in combination:

• Beta-blockers: Propranolol or metoprolol reduce heart rate and alleviate palpitations by blunting the sympathetic nervous system response.
• Fludrocortisone: This synthetic mineralocorticoid helps kidneys retain sodium and water, increasing blood volume and improving orthostatic tolerance.
• Midodrine: A vasoconstrictor that narrows blood vessels, increasing blood pressure and reducing blood pooling in the lower extremities upon standing.
• Ivabradine: Lowers heart rate by acting on the heart's sinus node, often without affecting blood pressure, useful for those intolerant to beta-blockers.
• Pyridostigmine: Improves autonomic neurotransmission by increasing acetylcholine levels, reducing tachycardia and improving gastrointestinal symptoms.

Addressing Underlying Mechanisms

If autoantibodies, SFN, or MCAS are identified, targeted treatments may be considered:

• For Autoimmunity: In severe cases, immunomodulatory therapies like Intravenous Immunoglobulin (IVIG) or plasmapheresis might be explored, reserved for refractory cases under specialized oversight.
• For MCAS: Treatment may involve H1 and H2 antihistamines (cetirizine, famotidine), mast cell stabilizers (cromolyn sodium), and leukotriene inhibitors to block inflammatory mediators.

The Importance of Mental Health and Support

Living with chronic, unpredictable, and often invisible illnesses like Long COVID and POTS significantly impacts mental health. Loss of independence, inability to participate in activities, and navigating a complex medical system can lead to anxiety, depression, and grief. Access to psychological support (therapy, support groups, patient advocacy organizations like Dysautonomia International) is crucial. Caregivers also play a vital role in emotional support and daily assistance.

Key Takeaways

References

[1] Blitshteyn, S., & Whitelaw, S. (2021). Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunologic Research, 69(2), 205-211. [2] Wallukat, G., Hohberger, B., Wenzel, K., Fürst, J., Schulze-Rothe, S., Wallukat, A., ... & Schimke, I. (2021). Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. Journal of Translational Autoimmunity, 4, 100100. [3] Oaklander, A. L., Mills, A. J., Kelley, M., Toran, L. S., Smith, B., Dalakas, M. C., & Nath, A. (2022). Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurology Neuroimmunology & Neuroinflammation, 9(3). [4] Afrin, L. B., Weinstock, L. B., & Molderings, G. J. (2020). Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. International Journal of Infectious Diseases, 100, 327-332.